Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Brain Research Bulletin

• Publication date

  1986-05-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/0361-9230(86)90131-0PMID 3488798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MPTP neurotoxicity: an overview and characterization of phases of toxicity.

  1985cited by this paper
• Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.

  1985cited by this paper
• Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)

  1985cited by this paper
• Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.

  1984cited by this paper
• Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.

  1984cited by this paper
• MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.

  1984cited by this paper
• Chronic low‐dose levodopa therapy in Parkinson's disease

  1984cited by this paper
• Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse.

  1984cited by this paper
• Problems of levodopa treatment.

  1984cited by this paper
• Anti-Parkinsonian Drugs Today

  1984cited by this paper
• Diagnostic problems in Parkinson's disease.

  1984cited by this paper
• Pargyline prevents MPTP-induced parkinsonism in primates.

  1984cited by this paper
• Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.

  1984cited by this paper
• Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s Disease

  1984cited by this paper
• What to do when Sinemet fails: Part one.

  1984cited by this paper
• Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

  1984cited by this paper
• Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.

  1984cited by this paper
• Acute administration of 1-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a compound producing parkinsonism in humans, stimulates [2-14C]deoxyglucose uptake in the regions of the catecholaminergic cell bodies in the rat and guinea pig brains.

  1984cited by this paper
• What to do when Sinemet fails: Part one.

  1984cited by this paper
• The Clinical Pathology of Parkinson’s Disease

  1983cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Parkinson’s Disease: Biochemistry, Clinical Pathology, and Treatment

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Galloping induced by pontine tegmentum damage in rats: a form of "Parkinsonian festination" not blocked by haloperidol.

  1981cited by this paper
• Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

  1979cited by this paper
• Biology Data Book

  1975cited by this paper
• AN ESSAY ON THE SHAKING PALSY

  1969cited by this paper
• Adequacy of liquid diets for maintenance of pig-tailed monkeys.

  1968cited by this paper
• The prevalence, natural history and dementia of Parkinson's disease.

  1966cited by this paper
• Blood and Other Body Fluids

  1961cited by this paper
• A sterotaxic atlas for cebus monkeys

  1960cited by this paper
• Primates : comparative anatomy and taxonomy

  1953cited by this paper

• Dissociation of tic generation from tic expression during the sleep-wake cycle

  2021cites this paper
• Dissociation of tic expression from its neuronal encoding in the striatum during sleep

  2020cites this paper
• A new animal model of paradoxical kinesia induced by 50-kHz ultrasonic vocalizations playback in rats: implications of the inferior colliculus

  2018cites this paper
• Kinesia paradoxa: a challenging Parkinson's phenomenon for simulation.

  2015cites this paper
• Motor behavior correlates with striatal [¹⁸F]-DOPA uptake in MPTP-lesioned primates.

  2013cites this paper
• Perturbations du contrôle traductionnel et troubles cognitifs dans un modèle expérimental de la maladie de Parkinson : études de neuroprotection

  2009cites this paper
• Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys.

  2008cites this paper
• THE NON-HUMAN PRIMATE AS A MODEL OF HUMAN PARKINSONISM

  2006cites this paper
• Modifications neurochimiques au sein des ganglions de la base et comportements moteurs associés lors d'une stimulation électrique du noyau subthalamique chez le rat hémiparkinsonien ou de la mise en place de la dénervation dopaminergique chez le singe

  2006cites this paper
• CHAPTER B2 – MPTP-Induced Nigrostriatal Injury in Nonhuman Primates

  2005cites this paper
• Inhibitory and excitatory processes in thalamic motor nuclei neurons in the normal nigrostriatal dopaminergic system and following injury to it produced by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

  2005cites this paper
• Chapter V Motor function(s) of the nigrostriatal dopamine system: Studies of lesions and behavior

  2005cites this paper
• Experimental reproduction of catecholamine-depleted states and parkinsonism — Theoretical and practical aspects

  2005cites this paper
• Disruption of self‐organized actions in monkeys with progressive MPTP‐induced parkinsonism: II. Effects of reward preference

  2004cites this paper
• Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

  2004cites this paper
• 6-18F-L-DOPA imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys

  2004cites this paper
• Noradrenergic mechanisms in neurodegenerative diseases: a theory.

  2004cites this paper
• Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons

  2004cites this paper
• Animal models of Parkinson's disease in rodents induced by toxins: an update.

  2003cites this paper
• Primate models of Parkinson's disease.

  2003cites this paper
• Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys.

  2000cites this paper
• Relación entre las alteraciones visoespaciales y los parámetros oculomotores en la Enfermedad de Parkinson

  2000cites this paper
• Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets

  1999cites this paper
• Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.

  1999cites this paper
• Functional and structural modifications in cells of theVA-VL thalamic nuclei under the influence of the neurotoxin MPTP

  1999cites this paper
• Animal models of tremor

  1999cites this paper
• Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease.

  1998cites this paper
• Amphetamine induces hypermotility in MPTP-lesioned mice.

  1997cites this paper
• Chronic L‐DOPA administration induces dyskinesias in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmoset (Callithrix jacchus)

  1995cites this paper
• Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.

  1995cites this paper
• The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.

  1994cites this paper
• Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys.

  1994cites this paper
• Behavioral Effects of MPTP Administration in the Vervet Monkey

  1994cites this paper
• Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated Monkeys

  1993cites this paper
• Effect of LY 171555 and CY 208‐243 on tremor suppression in the MPTP monkey model of parkinsonism

  1992cites this paper
• Effect of ethosuximide on rest tremor in the MPTP monkey model

  1992cites this paper
• Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.

  1992cites this paper
• Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.

  1991cites this paper
• Influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced injury of dopaminergic nigrostriatal system on movement components of the instrumental reflex and motor thalamic neurons' reactions in the cat.

  1991cites this paper
• Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.

  1991cites this paper
• Effects of an alpha 2 antagonist in a 20-year-old Java monkey with MPTP-induced parkinsonian signs.

  1991cites this paper
• Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.

  1990cites this paper
• [Anatomo-physiologic substratum of akinesia in primates].

  1990cites this paper
• Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier.

  1990cites this paper
• Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys.

  1990cites this paper
• MPTP-induced duodenal ulcers in rat: Prevention by reuptake blockers for serotonin and norepinephrine, but not dopamine

  1990cites this paper
• MPTP-induced duodenal ulcers in rat. Prevention by reuptake blockers for serotonin and norepinephrine, but not dopamine.

  1990cites this paper
• Selective brainstem injury in an asphyxiated newborn

  1988cites this paper
• Administration of MPTP acutely increases glucose utilization in the substantia nigra of primates.

  1988cites this paper
• Metabolic mapping of the oculomotor system in MPTP‐Induced parkinsonian monkeys

  1988cites this paper
• D1 and D2 Dopamine Receptors in Caudate‐Putamen of Nonhuman Primates (Macaca fascicularis)

  1988cites this paper
• Spatial Organization and Information Processing in the Core of the Basal Ganglia

  1987cites this paper
• Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.

  1987cites this paper